Copyright
©The Author(s) 2022.
World J Hepatol. Jul 27, 2022; 14(7): 1382-1397
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1382
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1382
Figure 3 Ingenuity Pathway Analysis of SREBF1 signaling in non-alcoholic fatty liver disease.
Genes are implicated in several potential disease processes including the inflammation, metabolism, and transport. Legend illustrates relationship between genes. See Figure 2 legend for identification of shapes. Figure generated using Ingenuity Pathway Analysis.
- Citation: Aljabban J, Rohr M, Syed S, Khorfan K, Borkowski V, Aljabban H, Segal M, Mukhtar M, Mohammed M, Panahiazar M, Hadley D, Spengler R, Spengler E. Transcriptome changes in stages of non-alcoholic fatty liver disease. World J Hepatol 2022; 14(7): 1382-1397
- URL: https://www.wjgnet.com/1948-5182/full/v14/i7/1382.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i7.1382